Impact of IBD Report
Who is Affected?
In the fall of 2012, Crohn’s and Colitis Canada released its report, “The Impact of Inflammatory Bowel Disease in Canada.” This landmark document revealed that approximately 233,000 Canadians suffer from Crohn’s disease and ulcerative colitis. Crohn’s and colitis are twice as common as multiple sclerosis or HIV and about as prevalent as epilepsy and Type 1 diabetes. One of the most troubling findings of this report is the significantly increasing prevalence of Crohn’s and colitis in children under 10, with an estimated 5,900 Canadian children affected.
The Costs of Crohn’s and Colitis
Canada has one of the highest incidences of Crohn’s and colitis in the world. With an annual economic cost of $2.8 billion, the burden of these diseases is significant. Beyond the economic impact, the personal hardship inflicted by these chronic diseases is incalculable. Quality of life, career choices, sense of self-worth, intimacy and personal freedoms are all affected when someone is affected by Crohn’s and colitis. With 10,200 new cases being diagnosed every year and incidence rates rising significantly, particularly in children under age 10, these diseases should be recognized as a national and provincial health priority.
The common challenges facing the Crohn’s and colitis community include, but are not limited to, dimensions of awareness, diagnosis, timely and equitable access to treatment and medications, health service delivery, employment, support systems and research. To improve quality of life and ultimately find cures for those affected, Crohn’s and Colitis Canada will continue to work with government, media, key stakeholders and the general public to advance public understanding of these chronic diseases and fund research that leads to improved treatment options and, ultimately, cures.
Impact Report 2012